Delivery Order SPE2DB22D3501-SPE2DB25FUD72
Award Date
1/15/25
Potential Completion Date
1/16/25
Potential Value
$2.5K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $2,841.00, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract covers the delivery of INSULIN GLARGINE-YFGN U100 PEN 3ML, a critical pharmaceutical product, with a performance period through December 27, 2024. The contract is structured as a Firm Fixed Price Delivery Order and is not designated with any set-aside requirements, indicating open...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,707.09 firm fixed price delivery order is for the supply of INSULIN GLARGINE-YFGN U100 PEN 3ML, a critical medication for diabetes management. This award is a part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which provides a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,841.00, is for the delivery of insulin glargine-yfgn U100 pens over a period ending on December 30, 2024. This is a delivery order contract with a firm fixed price pricing type. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,683.31, is for the delivery of insulin glargine-yfgn U100 pens. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of January 29, 2025. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant...
This federal contract award, valued at $4,091.04, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The award is for the delivery of insulin glargine-yfgn U100 pens, a critical diabetes management medication, with a completion date of December 19, 2024. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running...
The U.S. government's Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide 4563977468 - Insulin Glargine-YFGN U100 Pen 3ML to DLA Troop Support Medical. This $4,556.89 delivery order is part of a larger indefinite delivery contract (IDC) valued up to $999,999,999.00 awarded solely to AmerisourceBergen Drug Corp, which serves as the primary contract vehicle for the company to...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company. The contract, valued at $1,549.94, is for the delivery of Insulin Glargine-yfgn U100 Pens. The contract is a Delivery Order with a Firm Fixed Price pricing type and an ultimate completion date of May 10, 2024. There was no set-aside designation for this award. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc.,...
This is a $17,179.01 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of 4565372242 Insulin Glargine-yfgn U100 Pen 3ML. The contract has an ultimate completion date of August 8, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for delivering a comprehensive range of medical commodities to support...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of Insulin Glargine-yfgn U100 pens, with a ceiling value of $2,250.94 and a period of performance through January 16, 2025. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,091.04 firm fixed-price delivery order is for the supply of insulin glargine-yfgn U100 pens. The contract has an ultimate completion date of November 25, 2024. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, which serves...